Cardiovascular Health

Christopher Fine, MD, FACC, a cardiologist at National Jewish Health, discusses the relationship between heart disease and cancer and the importance of the field of cardio-oncology when treating patients with cancer.

Rivaroxaban is the only FDA-approved anticoagulant used in patients with peripheral artery disease and coronary artery disease.

The approval eliminates the need for traditional nitric oxide tanks in the hospital setting.

Investigators also noted that Black, Hispanic, and Asian individuals were less likely than white individuals to undergo timely angiography and had minimal changes overtime.

Clinical evaluation dictates the need for preventive therapy and advice on exercising and participation in competitive sports, according to the European Society of Cardiology.

Even if the financial resources were available, there aren’t enough human resources in pharmacy to provide high-touch engagement to the millions of patients who suffer from common chronic diseases.

Renin-angiotensin-aldosterone system inhibitors found to reduce the risk of an aneurysm rupture by 18%.

Inclisiran (Leqvio) is a small interfering ribonucleic acid approved by the FDA for patients who are on a maximally-tolerated dose of statins and need additional LDL-C reduction.

The findings show that at 90 days, the modified Rankin Score (mRS) had a significantly greater number of individuals with an improvement of 2 points or greater.

These real-world findings help support the use of DPI in patients at increased risk of vascular events.

Efforts to decrease hospital readmissions may have been misguided because the United States are already doing better than other high-income nations in this area.

Evinacumab-dgnb (Evkeeza) is indicated as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia.

When both the clinical criteria and genetic testing were combined, 6.6 familial hypercholesterolemia cases per 1000 individuals screened were found.

The use of cocaine can cause coronary artery vasospasm, which can lead to myocardial ischemia, acute coronary syndrome, and acute myocardial infarction.

Consequences for untreated STEMI patients following the COVID-19 pandemic could include increased mortality, heart failure, and morbidities.

This product helps control blood pressure.

But HRT is associated with positive changes to cholesterol levels, though the sample size was small, the analysis shows.

The use of certain drugs, such as statins, may lead to rhabdomyolysis.

Physicians often overlook those with lower BMIs who have nonalcoholic fatty liver disease and lower rates of other comorbidities, investigators say.

Asundexian was granted FDA Fast Track Designation based on a phase 2 study evaluating its safety and efficacy combined with antiplatelet therapy in patients following an acute, non-cardioembolic ischemic stroke.

The findings suggest that the broad use of race as a factor for providing certain health interventions and treatments should be reconsidered, investigators say.

Scientific abstracts also address findings on cardiovascular disease and population, the connection between COVID-19 and HF, and links between prognosis and marital status.

The advisory, published in Circulation, is a call to action for a cultural shift to identify and remove barriers.

The recommendations apply to individuals who are already taking the maximum dose of statins.

Results from the DELIVER and DAPA-HF phase 3 trials demonstrate AstraZeneca’s Farxiga’s efficacy in heart failure, regardless of ejection fraction.